Press "esc" to clear
Go to Advanced Search

Showing results

110 of 858
  • Embargo expired:
    19-Jul-2018 2:00 PM EDT

Article ID: 697455

Enzyme Identified as Possible Novel Drug Target for Sickle Cell Disease, Thalassemia

Children's Hospital of Philadelphia

Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease. Tests in human cells reveal that blocking the protein reduces the characteristic sickling that distorts the shape of red blood cells and gives the disease its name.

Released:
16-Jul-2018 3:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    19-Jul-2018 2:00 PM EDT

Article ID: 697587

Low/No Calorie Soft Drinks Improve Outcomes in Advanced Colon Cancer Patients

Yale Cancer Center

Drinking artificially-sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and cancer death, a team of investigators led by a Yale Cancer Center scientist has found. The study was published today in the journal The Public Library of Science One.

Released:
18-Jul-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
CrimpedandExpandedIMPEDE.jpg

Article ID: 697669

Memory Foam for Vascular Treatment Receives FDA Clearance

National Institute of Biomedical Imaging and Bioengineering

Shape Memory Medical recently announced FDA clearance for U.S. marketing of their IMPEDE Embolization Plug, a technology funded by NIBIB and created to block irregular blood vessels.

Released:
19-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
24-Jul-2018 11:00 AM EDT
Released to reporters:
19-Jul-2018 12:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Jul-2018 11:00 AM EDT

ALLgraphic_SIPKINS_edit2.jpg

Article ID: 697445

Researchers Solve Mystery of How ALL Enters the Central Nervous System

Duke Health

A research team led by Duke Cancer Institute scientists has found that this blood cancer infiltrates the central nervous system not by breaching the blood-brain barrier, but by evading the barrier altogether.

Released:
18-Jul-2018 1:00 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Embargo will expire:
23-Jul-2018 11:00 AM EDT
Released to reporters:
18-Jul-2018 10:25 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Jul-2018 11:00 AM EDT

Article ID: 697375

Missouri S&T Biochemical Engineer Patents Low-Cost Method of Removing Bacterial Toxins From Fluids

Missouri University of Science and Technology

By some estimates, 18 million people die each year from sepsis triggered by endotoxins – fragments of the outer membranes of bacteria. A biochemical engineer at Missouri University of Science and Technology has patented a method of removing these harmful elements from water and also from pharmaceutical formulations.Her goal: improve drug safety and increase access to clean drinking water in the developing world.

Released:
12-Jul-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    12-Jul-2018 9:00 AM EDT

Article ID: 697322

CDC Awards ASN Contract for Continued Dialysis Bloodstream Infection Research

American Society of Nephrology (ASN)

Bloodstream infections can be life-threatening to individuals undergoing kidney dialysis. Following infection control procedures is critical, yet best practices may not always occur at busy dialysis facilities.

Released:
12-Jul-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    11-Jul-2018 2:00 PM EDT

Article ID: 697245

Hepatitis C Vaccine Could Dramatically Reduce Transmission in People Who Inject Drugs

Loyola University Health System

If a hepatitis C vaccine were successfully developed, it would dramatically reduce transmission of hepatitis C among drug users. even if the vaccine did not provide complete immunity, according to a study published in Science Translational Medicine.

Released:
10-Jul-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    11-Jul-2018 1:00 PM EDT

Article ID: 697281

Rise of the Clones

Harvard Medical School

Researchers discover new clues about a recently identified blood cell condition known as clonal hematopoiesis, implicated in hematologic cancers, cardiovascular illness Surprisingly, the study reveals that inherited genetic variants can drive the condition by fueling additional mutations later in life The findings can help inform ways to gauge disease risk based on specific mutations, develop strategies to avert disease Clonal hematopoiesis is estimated to affect more than 1 in 10 people older than 65

Released:
11-Jul-2018 10:30 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 858





Chat now!